Dysautonomia Intl. on X: Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well to the medication. Read

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia International - Dysautonomia International, Vanderbilt University & University of Calgary recently published the first results from a survey of 4,800+ POTS patients. Our data shows about the same percentage of patients

Dysautonomia International

Dysautonomia Intl. (@Dysautonomia) / X

Frontiers Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?

Heart rate changes following the administration of sugammadex in children: a prospective, observational study

Dysautonomia Intl. (@Dysautonomia) / X

Pediatric Respiratory Dysfunction - Patient 2 Patient

Dysautonomia International

Dysautonomia International: 2015 Research Grant: Vasomotor Neuropathy in POTS

ABC Cardiol

Dysautonomia International on LinkedIn: Children's National researchers recently reported new research findings on…